Scholarly record
BRIEF ANALYSIS ON COMPETITION LAW IN THE PHARMACEUTICAL SECTOR AT THE LEVEL OF THE EUROPEAN UNION
Abstract
Given its importance for health services, the pharmaceutical sector is subject to strict regulations. The existing regulatory framework in this area should not include unnecessary regulatory constraints restricting and limiting competition. Considering this fact, this article analyzes the existing control in competition law on the pharmaceutical market achieved at EU level. This paper aims to present the complex mechanisms of the pharmaceutical sector that have undergone a careful and consistent analysis both the European Commission and the Competition Council. The supervision of the rules governing and guaranteeing the free competition existent on the pharmaceutical market and the direct and unambiguous intervention where breaches of the regulatory framework are detected ensures the existence of a competitive environment in the pharmaceutical sector in the European Union. The regulatory framework in which economic agents in the pharmaceutical sector operate should not include constraints.
Publication Impact Profile
- Captures
- Mendeley - Readers: 1
Publication details
ReferencesPending
Structured references will appear here after the reference import pass. The count is preserved now so the scholarly record is not incomplete.
View or Download full articleAccess options
SWS access login
Login as SWS Scientific CommitteeLogin as SWS Scientific PartnerLogin as SWS AuthorAuthors and approved SWS contributors will read and export their own linked papers after identity matching by SWS profile, email and SGEM GlobalID.
For librarian assistance: [email protected]
Purchase Instant Access
- Article can be downloaded after successful payment.
- Article may be used according to SWS library access terms.
- Article cannot be redistributed.
